Key Takeaways
- Shares of RKLB declined over 9% during Tuesday’s premarket session following uncertainty around Neutron’s launch timeline
- Management confirmed Neutron will arrive at the pad in Q4 2026, but stopped short of guaranteeing a launch this year
- The timeline shift suggests Neutron’s maiden voyage could be postponed until 2027, missing the company’s year-end goal
- Second quarter revenue climbed to an all-time high of $234.06M, reflecting 62% growth compared to last year and exceeding projections by $3.12M
- Contract backlog swelled to a record $2.36B in Q2, marking a 137% increase from the prior year
Shares of Rocket Lab experienced a sharp decline exceeding 9% in Tuesday’s premarket session after Chief Executive Peter Beck informed shareholders that the opportunity to launch Neutron before year-end is rapidly diminishing.
Management had previously suggested the company remained positioned to introduce Neutron by the close of 2025. Currently, the inaugural flight appears likely to shift into 2027.
The aerospace firm confirmed it continues targeting Q4 2026 for transporting Neutron to the launch facility. However, executives declined to provide assurance regarding an actual liftoff during that timeframe.
“The opportunity for a year-end launch continues to narrow,” Beck explained during the quarterly earnings discussion. “Our current focus centers on risk management, weighing the timeline for our inaugural launch against our ability to rapidly and efficiently expand operations.”
This marks another setback for Neutron’s development schedule. The reusable medium-class rocket has been under construction to challenge SpaceX’s Falcon 9 in the commercial launch market.
Neutron’s design targets satellite constellation launches, defense-related missions, and deep space exploration. Its reusable first stage represents a critical element of the vehicle’s economic competitiveness.
Strong Financial Performance Fails to Offset Investor Concerns
The timeline uncertainty eclipsed an otherwise impressive quarterly financial performance.
Second quarter revenue surged 62% compared to the same period last year, reaching a company record of $234.06M and surpassing Wall Street expectations by $3.12M.
The GAAP net loss per share improved to $0.08, versus $0.13 reported in the year-ago quarter.
The firm’s contract backlog reached an all-time high of $2.36B in Q2, representing 137% year-over-year expansion. Beck highlighted that additional agreements finalized after quarter-end bring new contract value beyond $1B for Q3 alone.
Rocket Lab announced over $437M in fresh launch contracts spanning its Electron, HASTE, and Neutron platforms during Q2 and the subsequent weeks.
This expanded the total launch manifest to exceed 90 missions, establishing yet another company milestone.
Future Outlook for Rocket Lab
For the upcoming quarter, Rocket Lab projected revenue between $250M and $265M. This forecast exceeds the Street consensus estimate of approximately $236M.
The robust guidance and expanding backlog demonstrate continued momentum in the company’s existing operations. Nevertheless, market participants remain fixated on Neutron’s development.
Neutron represents Rocket Lab’s gateway to competing in larger payload markets with enhanced margins. Any postponement to 2027 extends that strategic transition and introduces additional execution risk.
Beck refrained from committing to a specific date for Neutron’s debut flight. Company officials stated that manufacturing progress supports a Q4 pad arrival, though the precise launch window remains undefined.
The company’s complete launch manifest now encompasses more than 90 scheduled missions, underpinned by a record $2.36B backlog spanning both launch services and space systems segments.



